← The Wire
ORKANasdaq
Oruka Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 907654
Developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications
$4.22B
Market cap
$92.49
Last close
+2.1%
1D
+8.3%
5D
1.7M
Volume
Price · last 39 sessions+39.2%
May 4L $55.01 · H $92.49Jun 29
489
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 4, 20268-KCompany UpdateJun 1, 202610-QQUARTERLY REPORTMay 13, 2026SC 13D/ASC 13D/AMay 4, 20268-KResults of Operations · Company UpdateApr 30, 2026424B5PROSPECTUS SUPPLEMENTApr 29, 2026424B5PRELIMINARY PROSPECTUS SUPPLEMENTApr 27, 2026424B5PRELIMINARY PROSPECTUS SUPPLEMENTApr 27, 20268-KReg FD Disclosure · Company UpdateApr 27, 2026DEFA14APROXY STATEMENTApr 17, 2026DEF 14APROXY STATEMENTApr 17, 202610-KANNUAL REPORTMar 12, 20268-KExecutive ChangeDec 11, 202510-QQUARTERLY REPORTNov 12, 2025424B5PROSPECTUSNov 5, 20258-KMaterial Agreement · Equity IssuanceSep 22, 202510-QQUARTERLY REPORTAug 11, 20258-KExecutive ChangeJul 1, 20258-KShareholder VoteJun 3, 202510-QQUARTERLY REPORTMay 14, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 18, 2025DEF 14APROXY STATEMENTApr 18, 202510-KANNUAL REPORTMar 6, 20258-KMaterial AgreementFeb 5, 20258-KMaterial AgreementDec 19, 20248-KShareholder VoteNov 18, 20248-KCompany UpdateNov 14, 2024S-1REGISTRATION STATEMENTNov 14, 202410-QQUARTERLY REPORTNov 13, 2024DEF 14ADEF 14AOct 18, 2024SC 13GSC 13GOct 7, 20248-KExecutive ChangeOct 4, 20248-KMaterial Agreement · Equity IssuanceSep 13, 2024SC 13DSCHEDULE 13DSep 6, 20248-KAuditor Change · Change of ControlSep 5, 2024425CURRENT REPORTAug 27, 20248-KCompany UpdateAug 27, 20248-KShareholder Vote · Company UpdateAug 23, 2024425CURRENT REPORTAug 16, 20248-KCompany UpdateAug 16, 2024425CURRENT REPORTAug 15, 20248-KMaterial AgreementAug 15, 2024425FORM 425Aug 9, 2024425425Aug 1, 20248-KResults of OperationsAug 1, 202410-Q10-QAug 1, 2024425CURRENT REPORTJul 9, 20248-KMaterial AgreementJul 9, 2024425FORM 425Jun 6, 2024S-4REGISTRATION STATEMENTMay 14, 2024SC 13GSC 13GApr 29, 2024425425Apr 25, 20248-KResults of OperationsApr 25, 202410-Q10-QApr 25, 20248-KExecutive ChangeApr 23, 2024SC 13GSC 13GApr 15, 2024SC 13GJANUS HENDERSON GROUP PLC OWNS 7.4% OF ARCA BIOPHARMA, INCApr 11, 2024SC 13GSC 13GApr 9, 2024SC 13DARCA BIOPHARMA, INC.Apr 5, 20248-KExecutive ChangeApr 4, 2024425425Apr 3, 20248-KChange of Control · Executive ChangeApr 3, 20248-KMaterial AgreementMar 22, 20248-KExecutive ChangeFeb 6, 20248-KResults of OperationsFeb 1, 202410-K10-KFeb 1, 20248-KExecutive Change · Shareholder VoteJan 31, 2024DEFA14ADEFA14ADec 19, 2023DEF 14ADEF 14ADec 19, 20238-KCompany UpdateDec 5, 20238-KExecutive ChangeDec 4, 20238-KResults of OperationsOct 18, 202310-Q10-QOct 18, 2023SC 13GSC 13GSep 11, 20238-KResults of OperationsJul 21, 202310-Q10-QJul 21, 20238-KResults of OperationsApr 24, 202310-Q10-QApr 24, 20238-KResults of OperationsFeb 24, 202310-K10-KFeb 24, 2023
Insider Activity
In the 90 days to Mar 16, 2026: 5 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Goncalves JoanaChief Medical Officer | Sell | 2,902 | $41.20 | $120K |
| Mar 16, 2026 | Goncalves JoanaChief Medical Officer | Sell | 2,921 | $40.11 | $117K |
| Mar 16, 2026 | Klein Lawrence OttoChief Executive Officer | Sell | 1,729 | $41.30 | $71K |
| Mar 16, 2026 | Goncalves JoanaChief Medical Officer | Sell | 1,177 | $41.94 | $49K |
| Mar 16, 2026 | Quinlan Paul TGeneral Counsel | Sell | 733 | $41.30 | $30K |
| Mar 16, 2026 | Goncalves JoanaChief Medical Officer | Sell | 641 | $41.30 | $26K |
| Mar 16, 2026 | Sandler Laura LeeChief Operating Officer | Sell | 600 | $41.30 | $25K |
| Mar 16, 2026 | Agarwal ArjunSenior Vice President, Finance | Sell | 395 | $41.30 | $16K |
| Mar 2, 2026 | Sandler Laura LeeChief Operating Officer | Sell | 2,675 | $33.81 | $90K |
| Mar 2, 2026 | Sandler Laura LeeChief Operating Officer | Sell | 2,325 | $33.28 | $77K |
| Feb 17, 2026 | Goncalves JoanaChief Medical Officer | Sell | 6,064 | $32.30 | $196K |
| Feb 17, 2026 | Goncalves JoanaChief Medical Officer | Sell | 936 | $32.78 | $31K |
| Jan 15, 2026 | Goncalves JoanaChief Medical Officer | Sell | 4,381 | $31.56 | $138K |
| Jan 15, 2026 | Goncalves JoanaChief Medical Officer | Sell | 2,619 | $32.24 | $84K |
| Jan 2, 2026 | Sandler Laura LeeChief Operating Officer | Sell | 8,748 | $28.17 | $246K |
| Jan 2, 2026 | Sandler Laura LeeChief Operating Officer | Sell | 3,144 | $29.08 | $91K |
| Jan 2, 2026 | Sandler Laura LeeChief Operating Officer | Sell | 1,108 | $29.75 | $33K |
| Dec 19, 2025 | Goncalves JoanaChief Medical Officer | Sell | 3,080 | $31.58 | $97K |
| Dec 19, 2025 | Goncalves JoanaChief Medical Officer | Sell | 1,787 | $29.62 | $53K |
| Dec 19, 2025 | Goncalves JoanaChief Medical Officer | Sell | 1,492 | $30.70 | $46K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance